Cannabidiol for the treatment of cannabis use disorder: Phase IIa double-blind placebo-controlled randomised adaptive Bayesian dose-finding trial

BACKGROUND: There is a substantial and unmet clinical need for pharmacological treatment of cannabis use disorders. Cannabidiol (CBD) could offer a novel treatment but it is unclear which doses might be effective or safe. METHODS: Participants meeting DSM-5 cannabis use disorder criteria were alloca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Psychiatry
Main Authors: Freeman, Tom P, Hindocha, Chandni, Baio, Gianluca, Shaban, Natacha DC, Thomas, Emily, Astbury, Danica, Freeman, Abigail M, Lees, Rachel, Craft, Sam, Morrison, Paul D, Bloomfield, Michael AP, O’Ryan, Dominic, Kinghorn, Jane, Morgan, Celia JA, Mofeez, Ali, Curran, H Valerie
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7116091/
https://ncbi.nlm.nih.gov/pubmed/32735782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2215-0366(20)30290-X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados